SCHEMBL4895352

SCHEMBL4895352

CCN(c1ccc(OCc2ccc(C)cc2)cc1)S(=O)(=O)c1ccc(C)c(C(=O)O)c1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.54
KEAP1 Q14145 4/20 0.50
NFE2L2 Q16236 4/20 0.50
LMNA P02545 1/20 0.50
ALDH1A1 P00352 1/20 0.49
HPGD P15428 1/20 0.49
ALOX15 P16050 1/20 0.49
HSD17B10 Q99714 1/20 0.49
MMP9 P14780 1/20 0.47
MMP13 P45452 1/20 0.47
ADAM17 P78536 1/20 0.47
PTGES O14684 1/20 0.47
ALOX5 P09917 1/20 0.47
KDM4E B2RXH2 1/20 0.46
CNR1 P21554 1/20 0.45
CNR2 P34972 1/20 0.45
ESR1 P03372 1/20 0.45
MCL1 Q07820 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4905993 0.93 LMNA (0.56) KMT2AKEAP1NFE2L2LMNAALDH1A1
SCHEMBL4907030 0.92 LMNA (0.51) KMT2ALMNAALDH1A1HPGDALOX15
SCHEMBL4897482 0.92 LMNA (0.53) KMT2AKEAP1NFE2L2LMNAALDH1A1
SCHEMBL4895594 0.92 LMNA (0.50) KMT2ALMNAALDH1A1HPGDALOX15
SCHEMBL4902970 0.90 KEAP1 (0.48) KMT2AKEAP1NFE2L2LMNAALDH1A1
SCHEMBL4905308 0.89 MMP2 (0.49) KMT2AKEAP1NFE2L2LMNAALDH1A1
SCHEMBL4903420 0.88 LMNA (0.57) KMT2AKEAP1NFE2L2LMNAALDH1A1
SCHEMBL4904188 0.88 LMNA (0.53) KMT2AKEAP1NFE2L2LMNAALDH1A1
SCHEMBL4909094 0.85 LMNA (0.58) KEAP1NFE2L2LMNAALDH1A1HPGD
SCHEMBL4905129 0.84 MMP13 (0.52) KEAP1NFE2L2LMNAALDH1A1MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD KMT2A 3602/4885KEAP1 714/4885NFE2L2 451/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD KMT2A 3530/4885KEAP1 810/4885NFE2L2 446/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD KMT2A 3530/4885KEAP1 810/4885NFE2L2 446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.